Big Gain For Dermata Therapeutics, Inc.
Mon, Jan 26, 2026 at 07:18 PM
Dermata Therapeutics, Inc. (DRMA:NASDAQ) soared at $3.08, representing a gain of 41.9%. On Mon, Jan 26, 2026, DRMA:NASDAQ hit a New 2-Week High of $3.08. The stock got featured on our News Catalysts scanner on Tue, Jan 20, 2026 at 10:14 AM in the 'PRIVATE PLACEMENT' category. From Mon, Jan 12, 2026, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Mon, Jan 26, 2026 at $4.66 with a volume of 27M+.
About Dermata Therapeutics, Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Brand Engagement Network, Inc. (BNAI:NASDAQ), 276.7%
- Battalion Oil Corporation (BATL:NYSEMKT), 211.72%
- Check-Cap Ltd. (MBAI:NASDAQ), 112.08%
- Pheton Holdings Ltd (PTHL:NASDAQ), 105.16%
- Smart Logistics Global Limited (SLGB:NASDAQ), 103.28%
- X3 Holdings Co., Ltd. (XTKG:NASDAQ), 94.32%
- Gauzy Ltd. (GAUZ:NASDAQ), 59.63%
- Solo Brands Inc. Class A (SBDS:NYSE), 43.09%
- Dermata Therapeutics, Inc. (DRMA:NASDAQ), 41.94%
- Nauticus Robotics, Inc. (KITT:NASDAQ), 40.08%